Step by Step: A Tailored Walking Intervention for Breast Cancer Survivors
NCT ID: NCT01845519
Last Updated: 2015-06-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
90 participants
INTERVENTIONAL
2013-07-31
2014-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The investigators hypothesize that at the end of 12-weeks, participants randomized to the intervention group will engage in more weekly steps than those participants randomized to the comparison group.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Impact of a Physical Activity Program on Biomarkers of Aging During Chemotherapy for Breast Cancer
NCT02167932
Effectiveness of a Cancer Center Based Physical Activity Intervention
NCT01173861
Impact of Physical Activity on Biomarker of Aging and Body Composition Among Breast Cancer Survivors Age 65 and Older
NCT02328313
Enhancing Exercise in Breast Cancer Survivors
NCT01849978
Feasibility of High Levels of Energy Expenditure From Physical Activity for Breast Cancer Survivors
NCT02963740
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
AIM 1: Develop and test intervention (tailored) and comparison group (targeted) messages in a sample of sedentary women to determine message acceptability.
AIM 2: Determine the efficacy of a 12-week tailored intervention to increase the number of weekly steps taken among sedentary post-treatment breast cancer survivors compared to a 12-week, targeted intervention.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Tailored Group
Tailored Email
Participants will receive tailored emails.
Targeted Group
Targeted Email
Participants will receive targeted emails.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Tailored Email
Participants will receive tailored emails.
Targeted Email
Participants will receive targeted emails.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 40-70 years of age
* History of breast cancer stage I-II
* 2-10 years post-treatment
* Sedentary
* Technology access and skills
* Regular access to personal computer/ broadband internet and email account
* Comfortability using internet, and web-based tools
* US Resident
Exclusion Criteria
* Current secondary cancer diagnosis/ treatment
* Inability to ambulate
* Refusal to wear personal activity monitor (FitBit Ultra) for the duration of the study
* Engaging in regular moderate to vigorous physical activity
40 Years
70 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
UNC Lineberger Comprehensive Cancer Center
OTHER
University of North Carolina
OTHER
Leanne Kaye
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Leanne Kaye
Doctoral Candidate
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Leanne Kaye, PhD
Role: PRINCIPAL_INVESTIGATOR
University of North Carolina
Dianne Ward, Ed.D
Role: STUDY_DIRECTOR
University of North Carolina
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Lineberger Comprehensive Cancer Center/ University of North Carolina
Chapel Hill, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB 121775
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.